The association between histological prostatitis and benign prostatic hyperplasia: a single-center retrospective study

References

• Launer BM, McVary KT, Ricke WA, et al. The rising worldwide impact of benign prostatic hyperplasia. BJU Int. 2021;127(6):722–728.
   PubMed Web of Science ®Google Scholar
• Wei JT, Calhoun E, Jacobsen SJ. Urologic diseases in America project: benign prostatic hyperplasia. J Urol. 2008;179(5 Suppl):S75–S80.
   PubMed Web of Science ®Google Scholar
• Vignozzi L, Gacci M, Maggi M. Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome. Nat Rev Urol. 2016;13(2):108–119.
   PubMed Web of Science ®Google Scholar
• Sarier M, Tekin S, Duman İ, et al. Results of transurethral resection of the prostate in renal transplant recipients: a single center experience. World J Urol. 2018;36(1):99–103.
   PubMed Web of Science ®Google Scholar
• Sarier M, Duman I, Kilic S, et al. Comparative results of transurethral incision with transurethral resection of the prostate in renal transplant recipients with benign prostate hyperplasia. Urol J. 2018;15(4):209–213.
   PubMed Web of Science ®Google Scholar
• Grzesiak K, Rył A, Baranowska-Bosiacka I, et al. Comparison between selected hormone and protein levels in serum and prostate tissue homogenates in men with benign prostatic hyperplasia and metabolic disorders. Clin Interv Aging. 2018;13:1375–1382.
   PubMed Web of Science ®Google Scholar
• Li J, Peng L, Cao D, et al. The association between metabolic syndrome and benign prostatic hyperplasia: a systematic review and meta-analysis. Aging Male. 2020;23(5):1388–1399.
   PubMed Web of Science ®Google Scholar
• Jeh SU, Yoon S, Seo DH, et al. Relationship between serum testosterone and nocturia in men without benign prostate enlargement. Andrology. 2017;5(1):58–62.
   PubMed Web of Science ®Google Scholar
• Chang WH, Tsai YS, Wang JY, et al. Sex hormones and oxidative stress mediated phthalate-induced effects in prostatic enlargement. Environ Int. 2019;126:184–192.
   PubMed Web of Science ®Google Scholar
• Gandaglia G, Briganti A, Gontero P, et al. The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH). BJU Int. 2013;112(4):432–441.
   PubMed Web of Science ®Google Scholar
• Song L, Zhu Y, Han P, et al. A retrospective study: correlation of histologic inflammation in biopsy specimens of Chinese men undergoing surgery for benign prostatic hyperplasia with serum prostate-specific antigen. Urology. 2011;77(3):688–692.
   PubMed Web of Science ®Google Scholar
• Moreira DM, Nickel JC, Gerber L, et al. Smoking is associated with acute and chronic prostatic inflammation: results from the REDUCE study. Cancer Prev Res. 2015;8(4):312–317.
   PubMed Web of Science ®Google Scholar
• Robert G, Descazeaud A, Nicolaïew N, et al. Inflammation in benign prostatic hyperplasia: a 282 patients' immunohistochemical analysis. Prostate. 2009;69(16):1774–1780.
   PubMed Web of Science ®Google Scholar
• Nickel JC, True LD, Krieger JN, et al. Consensus development of a histopathological classification system for chronic prostatic inflammation. BJU Int. 2001;87(9):797–805.
   PubMed Web of Science ®Google Scholar
• Bostwick DG, de la Roza G, Dundore P, et al. Intraepithelial and stromal lymphocytes in the normal human prostate. Prostate. 2003;55(3):187–193.
   PubMed Web of Science ®Google Scholar
• Steiner GE, Stix U, Handisurya A, et al. Cytokine expression pattern in benign prostatic hyperplasia infiltrating T cells and impact of lymphocytic infiltration on cytokine mRNA profile in prostatic tissue. Lab Invest. 2003;83(8):1131–1146.
   PubMed Web of Science ®Google Scholar
• De Nunzio C, Presicce F, Tubaro A. Inflammatory mediators in the development and progression of benign prostatic hyperplasia. Nat Rev Urol. 2016;13(10):613–626.
   PubMed Web of Science ®Google Scholar
• Kramer G, Mitteregger D, Marberger M. Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Eur Urol. 2007;51(5):1202–1216.
   PubMed Web of Science ®Google Scholar
• Bostanci Y, Kazzazi A, Momtahen S, et al. Correlation between benign prostatic hyperplasia and inflammation. Curr Opin Urol. 2013;23(1):5–10.
   PubMed Web of Science ®Google Scholar
• Nickel JC, Roehrborn CG, O'Leary MP, et al. The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial. Eur Urol. 2008;54(6):1379–1384.
   PubMed Web of Science ®Google Scholar
• Cao DH, Liu LR, Li L, et al. Pathological characteristics of CD40/CD40L and NF-κB proteins related to inflammation in benign prostatic hyperplasia tissue: a retrospective study of 120 cases. Int J Clin Exp Pathol. 2017;10(11):10863–10872.
   PubMed Web of Science ®Google Scholar
• Torkko KC, Wilson RS, Smith EE, et al. Prostate biopsy markers of inflammation are associated with risk of clinical progression of benign prostatic hyperplasia: findings from the MTOPS study. J Urol. 2015;194(2):454–461.
   PubMed Web of Science ®Google Scholar
• Rastrelli G, Vignozzi L, Corona G, et al. Testosterone and benign prostatic hyperplasia. Sex Med Rev. 2019;7(2):259–271.
   PubMed Web of Science ®Google Scholar
• Asiedu B, Anang Y, Nyarko A, et al. The role of sex steroid hormones in benign prostatic hyperplasia. Aging Male. 2017;20(1):17–22.
   PubMed Web of Science ®Google Scholar
• Liao CH, Li HY, Chung SD, et al. Significant association between serum dihydrotestosterone level and prostate volume among Taiwanese men aged 40-79 years. Aging Male. 2012;15(1):28–33.
   PubMed Web of Science ®Google Scholar
• Lee JH, Kim Y, Park YW, et al. Relationship between benign prostatic hyperplasia/lower urinary tract symptoms and total serum testosterone level in healthy Middle-aged Eugonadal men. J Sex Med. 2014;11(5):1309–1315.
   PubMed Web of Science ®Google Scholar
• Wu Y, Pan H, Wang WM, et al. A possible relationship between serum sex hormones and benign prostatic hyperplasia/lower urinary tract symptoms in men who underwent transurethral prostate resection. Asian J Androl. 2017;19(2):230–233.
   PubMed Web of Science ®Google Scholar
• Zheng R, Hu H. Correlative analysis of the level of estrogen and androgen hormones and symptom indexes in 60 patients with benign prostatic hyperplasia. Chin J Trad Chin Med Pharm. 2018;33(6):2568–2570.
   Google Scholar
• Tong Y, Zhou RY. Review of the roles and interaction of androgen and inflammation in benign prostatic hyperplasia. Mediators Inflamm. 2020;2020:7958316.
   PubMed Web of Science ®Google Scholar
• Buyukkaya E, Karakaş MF, Karakaş E, et al. Correlation of neutrophil to lymphocyte ratio with the presence and severity of metabolic syndrome. Clin Appl Thromb Hemost. 2014;20(2):159–163.
   PubMed Web of Science ®Google Scholar
• Guo X, Zhang S, Zhang Q, et al. Neutrophil:lymphocyte ratio is positively related to type 2 diabetes in a large-scale adult population: a Tianjin chronic Low-Grade systemic inflammation and health cohort study. Eur J Endocrinol. 2015;173(2):217–225.
   PubMed Web of Science ®Google Scholar
• Furuncuoğlu Y, Tulgar S, Dogan AN, et al. How obesity affects the neutrophil/lymphocyte and platelet/lymphocyte ratio, systemic immune-inflammatory index and platelet indices: a retrospective study. Eur Rev Med Pharmacol Sci. 2016;20(7):1300–1306.
   PubMed Web of Science ®Google Scholar
• Tanik S, Albayrak S, Zengin K, et al. Is the neutrophil-lymphocyte ratio an indicator of progression in patients with benign prostatic hyperplasia? Asian Pac J Cancer Prev. 2014;15(15):6375–6379.
   PubMedGoogle Scholar
• Ozer K, Horsanali MO, Gorgel SN, et al. Association between benign prostatic hyperplasia and Neutrophil-Lymphocyte ratio, an indicator of inflammation and metabolic syndrome. Urol Int. 2017;98(4):466–471.
   PubMed Web of Science ®Google Scholar
• Kang JY, Choi JD, Cho JM, et al. Association of neutrophil-to-Lymphocyte ratio, platelet-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio with benign prostatic hyperplasia: a propensity score-matched analysis. Urol Int. 2021;105(9-10):811–816.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Pang S, Zhang Y, et al. Association between inflammation and lower urinary tract symptoms of benign prostatic hyperplasia. Urol J. 2020;17(5):505–511.
   PubMed Web of Science ®Google Scholar